Vor BiopharmaVOR
13F holders, Q3 2025 (September 30)1holders −33
0new positions
9sold out
$48.72avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Vor Biopharma Inc. (VOR) in their 13F filings, down 33 from Q2 2025. 0 opened new positions and 9 sold out. The largest holder was Johnson & Johnson ($2.6M).
- Company
- Vor Biopharma Inc.
- CUSIP
- 929033108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 9 | $11.9M |
All 13F filers, Q2 2025 → Q3 2025: 8,333,986 shares sold, net −8,333,986 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Johnson & Johnson | 0.52% | Reduce -95.0% | 53,732 | $2.6M |
"% of holder's portfolio" is VOR's weight in each manager's 13F, not the share of Vor Biopharma Inc. the manager owns.